×
About 48,214 results

ALLMedicine™ Migraine Center

Research & Reviews  21,729 results

Migraine Improvement During COVID-19 Pandemic - A Case Report on the Wonders of a Mask.
https://doi.org/10.1111/head.13964
Headache References; Martins B, Costa A

Sep 24th, 2020 - Migraine Improvement During COVID-19 Pandemic - A Case Report on the Wonders of a Mask.|2020|Martins B,Costa A,|

Safety and Tolerability of 3 CGRP Monoclonal Antibodies in Practice: A Retrospective Co...
https://doi.org/10.1111/head.13956
Headache REFERENCES; Alex A, Vaughn C et. al.

Sep 24th, 2020 - We sought to assess the safety and tolerability of 3 calcitonin gene-related peptide (CGRP) monoclonal antibodies in patients with chronic migraine who have failed multiple classes of migraine preventive therapies. CGRP is an important neuromodula...

Peripheral changes of endocannabinoid system components in episodic and chronic migrain...
https://doi.org/10.1177/0333102420949201
Cephalalgia : an International Journal of Headache; Greco R, Demartini C et. al.

Sep 24th, 2020 - Preclinical and clinical evidence suggests a role for the dysregulation of the endocannabinoid system in migraine pain, particularly in subjects with chronic migraine. The gene expression of endocannabinoid system components was assayed in periphe...

Functional gene networks reveal distinct mechanisms segregating in migraine families.
https://doi.org/10.1093/brain/awaa242
Brain : a Journal of Neurology; Rasmussen AH, Kogelman LJA et. al.

Sep 24th, 2020 - Migraine is the most common neurological disorder worldwide and it has been shown to have complex polygenic origins with a heritability of estimated 40-70%. Both common and rare genetic variants are believed to underlie the pathophysiology of the ...

The Efficacy of Lasmiditan for the Treatment of Migraine: A Meta-Analysis of Randomized...
https://doi.org/10.1097/WNF.0000000000000417
Clinical Neuropharmacology; Zhu H, Tang Y et. al.

Sep 24th, 2020 - The efficacy of lasmiditan is used to alleviate migraine. We conduct a systematic review and meta-analysis to explore the influence of lasmiditan versus placebo on pain control in patients with migraine. We search the PubMed, EMbase, Web of scienc...

see more →

Guidelines  43 results

ACR Appropriateness Criteria® Cerebrovascular Disease-Child.
https://doi.org/10.1016/j.jacr.2020.01.036
Journal of the American College of Radiology : JACR; , Robertson RL et. al.

May 5th, 2020 - Stroke is an uncommon but an important and under-recognized cause of morbidity and mortality in children. Strokes may be due to either brain ischemia or intracranial hemorrhage. Common symptoms of pediatric acute stroke include headache, vomiting,...

Acupuncture for Pain
https://www.aafp.org/afp/2019/0715/p89.html
American Family Physician; Kelly,R.,et al

Jul 14th, 2019 - Acupuncture has been increasingly used as an integrative or complementary therapy for pain. It is well-tolerated with little risk of serious adverse effects. Traditional acupuncture and nontraditional techniques, such as electroacupuncture and dry...

Association Between Food Insecurity and Migraine Among US Young Adults
https://jamanetwork.com/journals/jamaneurology/article-abstract/2736340
JAMA Neurology; Nagata,J.,et al

Jun 23rd, 2019 - Food insecurity, defined as limited or intermittent access to nutritionally adequate and safe foods, accessed in socially acceptable ways, is associated with numerous adverse physical and mental health outcomes.1 One in 6 individuals are affected ...

Aids to management of headache disorders in primary care (2nd edition) : on behalf of t...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734476
The Journal of Headache and Pain; Steiner TJ, Jensen R et. al.

May 22nd, 2019 - The Aids to Management are a product of the Global Campaign against Headache, a worldwide programme of action conducted in official relations with the World Health Organization. Developed in partnership with the European Headache Federation, they ...

European headache federation guideline on the use of monoclonal antibodies acting on th...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734227
The Journal of Headache and Pain; Sacco S, Bendtsen L et. al.

Jan 17th, 2019 - Monoclonal antibodies acting on the calcitonin gene-related peptide or on its receptor are new drugs to prevent migraine. Four monoclonal antibodies have been developed: one targeting the calcitonin gene-related peptide receptor (erenumab) and thr...

see more →

Drugs  1,145 results see all →

Clinicaltrials.gov  23,321 results

Migraine Improvement During COVID-19 Pandemic - A Case Report on the Wonders of a Mask.
https://doi.org/10.1111/head.13964
Headache References; Martins B, Costa A

Sep 24th, 2020 - Migraine Improvement During COVID-19 Pandemic - A Case Report on the Wonders of a Mask.|2020|Martins B,Costa A,|

Safety and Tolerability of 3 CGRP Monoclonal Antibodies in Practice: A Retrospective Co...
https://doi.org/10.1111/head.13956
Headache REFERENCES; Alex A, Vaughn C et. al.

Sep 24th, 2020 - We sought to assess the safety and tolerability of 3 calcitonin gene-related peptide (CGRP) monoclonal antibodies in patients with chronic migraine who have failed multiple classes of migraine preventive therapies. CGRP is an important neuromodula...

Peripheral changes of endocannabinoid system components in episodic and chronic migrain...
https://doi.org/10.1177/0333102420949201
Cephalalgia : an International Journal of Headache; Greco R, Demartini C et. al.

Sep 24th, 2020 - Preclinical and clinical evidence suggests a role for the dysregulation of the endocannabinoid system in migraine pain, particularly in subjects with chronic migraine. The gene expression of endocannabinoid system components was assayed in periphe...

Functional gene networks reveal distinct mechanisms segregating in migraine families.
https://doi.org/10.1093/brain/awaa242
Brain : a Journal of Neurology; Rasmussen AH, Kogelman LJA et. al.

Sep 24th, 2020 - Migraine is the most common neurological disorder worldwide and it has been shown to have complex polygenic origins with a heritability of estimated 40-70%. Both common and rare genetic variants are believed to underlie the pathophysiology of the ...

The Efficacy of Lasmiditan for the Treatment of Migraine: A Meta-Analysis of Randomized...
https://doi.org/10.1097/WNF.0000000000000417
Clinical Neuropharmacology; Zhu H, Tang Y et. al.

Sep 24th, 2020 - The efficacy of lasmiditan is used to alleviate migraine. We conduct a systematic review and meta-analysis to explore the influence of lasmiditan versus placebo on pain control in patients with migraine. We search the PubMed, EMbase, Web of scienc...

see more →

News  1,899 results

Cigna's Express Scripts offers discounted drugs for U.S. newly unemployed
https://www.reuters.com/article/us-cigna-prescriptions/cignas-express-scripts-offers-discounted-drugs-for-u-s-newly-unemployed-idUSKBN22J1AT

May 7th, 2020 - NEW YORK (Reuters) - Express Scripts is offering discounted $25 and $75 prescription drug prices to the newly uninsured, a stop-gap measure aimed at Americans who lose their jobs and health insurance due to the coronavirus pandemic. The U.S. pharm...

Migraine tied to risk of comorbidities 
https://www.mdedge.com/neurology/migraineresourcecenter/article/220131/headache-migraine/migraine-tied-risk-comorbidities?channel=63462

Apr 2nd, 2020 - Key clinical point: Patients with migraine have an increased risk for comorbidities, and the risk is influenced by headache pain intensity and monthly headache days. Major finding : Patients with migraine vs those without had an increased risk for.

Topical basil essential oil reduces severity and frequency of migraine attacks
https://www.mdedge.com/neurology/migraineresourcecenter/article/220130/headache-migraine/topical-basil-essential-oil?channel=63462

Apr 2nd, 2020 - Key clinical point: Topical basil essential oil at higher doses can effectively reduce the severity of pain intensity and frequency of migraine attacks. Major Finding: The interaction between dose and time factors was significantly associated with.

Cervical nVNS is safe and effective for acute pain relief in migraine and cluster headaches
https://www.mdedge.com/neurology/migraineresourcecenter/article/220128/headache-migraine/cervical-nvns-safe-and-effective?channel=63462

Apr 2nd, 2020 - Key clinical point: Cervical noninvasive vagus nerve stimulation (nVNS) is a safe and effective technique for relieving acute pain in migraine and cluster headaches. Major finding : The nVNS vs.

Pediatric migraine: Topiramate reduces monthly headache days and disability
https://www.mdedge.com/neurology/migraineresourcecenter/article/220127/headache-migraine/pediatric-migraine-topiramate?channel=63462

Apr 2nd, 2020 - Key clinical point: Topiramate can reduce the number of headache days in a month and disability levels in children with migraine. Major finding: Topiramate vs.

see more →

Patient Education  77 results see all →